Pharmacoepidemiology: the lessons learned; the challenges ahead.

Suppr

超能文献

作者信息

Tilson H H

出版信息

Clin Pharmacol Ther. 1989 Oct;46(4):480. doi: 10.1038/clpt.1989.170.

DOI:10.1038/clpt.1989.170

PMID:2791452

Abstract

摘要

相似文献

Pharmacoepidemiology: the lessons learned; the challenges ahead.

Clin Pharmacol Ther. 1989 Oct;46(4):480. doi: 10.1038/clpt.1989.170.

Uninformed criticism of automated record linkage.

Clin Pharmacol Ther. 1989 Oct;46(4):478-9. doi: 10.1038/clpt.1989.168.

Automated record linkage: a response to the commentary and letters to the editor.

Clin Pharmacol Ther. 1989 Oct;46(4):395-8. doi: 10.1038/clpt.1989.157.

Record linkage for postmarketing surveillance.

Clin Pharmacol Ther. 1989 Oct;46(4):479-80. doi: 10.1038/clpt.1989.169.

The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.

Clin Pharmacol Ther. 1989 Oct;46(4):371-86. doi: 10.1038/clpt.1989.154.

The future of automated record linkage for postmarketing surveillance: a response to Shapiro.

Clin Pharmacol Ther. 1989 Oct;46(4):387-9. doi: 10.1038/clpt.1989.155.

The role of record linkage in post-marketing drug surveillance.

Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):77S-82S. doi: 10.1111/j.1365-2125.1986.tb02987.x.

Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.

Drug Intell Clin Pharm. 1988 Feb;22(2):157-61. doi: 10.1177/106002808802200216.

Postmarketing surveillance--how should doctors get involved?

Drug Ther Bull. 1988 Nov 14;26(23):89-91.

Postmarketing drug surveillance by record linkage in Tayside.

J Epidemiol Community Health. 1984 Sep;38(3):226-31. doi: 10.1136/jech.38.3.226.

引用本文的文献

Pharmacoepidemiology in practice. Current status and future trends.

Drug Saf. 1995 Jul;13(1):1-7. doi: 10.2165/00002018-199513010-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacoepidemiology: the lessons learned; the challenges ahead.

Clin Pharmacol Ther. 1989 Oct;46(4):480. doi: 10.1038/clpt.1989.170.

Uninformed criticism of automated record linkage.

Clin Pharmacol Ther. 1989 Oct;46(4):478-9. doi: 10.1038/clpt.1989.168.

Automated record linkage: a response to the commentary and letters to the editor.

Clin Pharmacol Ther. 1989 Oct;46(4):395-8. doi: 10.1038/clpt.1989.157.

Record linkage for postmarketing surveillance.

Clin Pharmacol Ther. 1989 Oct;46(4):479-80. doi: 10.1038/clpt.1989.169.

The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.

Clin Pharmacol Ther. 1989 Oct;46(4):371-86. doi: 10.1038/clpt.1989.154.

The future of automated record linkage for postmarketing surveillance: a response to Shapiro.

Clin Pharmacol Ther. 1989 Oct;46(4):387-9. doi: 10.1038/clpt.1989.155.

The role of record linkage in post-marketing drug surveillance.

Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):77S-82S. doi: 10.1111/j.1365-2125.1986.tb02987.x.

Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.

Drug Intell Clin Pharm. 1988 Feb;22(2):157-61. doi: 10.1177/106002808802200216.

Postmarketing surveillance--how should doctors get involved?

Drug Ther Bull. 1988 Nov 14;26(23):89-91.

Postmarketing drug surveillance by record linkage in Tayside.

J Epidemiol Community Health. 1984 Sep;38(3):226-31. doi: 10.1136/jech.38.3.226.

引用本文的文献

Pharmacoepidemiology in practice. Current status and future trends.

Drug Saf. 1995 Jul;13(1):1-7. doi: 10.2165/00002018-199513010-00001.